Today: 25 January 2026
Subscribe
Browse Category

NASDAQ:WVE News 9 January 2026 - 11 January 2026

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

New York, January 10, 2026, 21:25 EST — Market closed Shares of Wave Life Sciences Ltd dropped 6.7% on Friday, ending the day at $13.84. The stock swung between a high of $15.09 and a low of $13.76 during the session. As the J.P. Morgan Healthcare Conference week kicks off, investors are eyeing Wave’s stock for any new insights on…
11 January 2026
·····
Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now

Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now

New York, January 9, 2026, 13:20 (EST) — Regular session Wave Life Sciences Ltd shares fell about 5.6% on Friday, down 83 cents at $14.00, after trading between $13.99 and $15.09. The drop came even as biotech exchange-traded funds rose, with the SPDR S&P Biotech ETF up about 1% and the iShares Nasdaq Biotechnology ETF up about 0.5%. The move…
9 January 2026
·····

Stock Market Today

  • Planet Labs (PL) Shares Surge Amid Overvaluation Concerns
    January 24, 2026, 11:40 PM EST. Planet Labs PBC (PL) has seen its share price surge 39.2% over 30 days, with a remarkable 395.2% gain over one year. Despite this strong performance, valuation metrics suggest caution. Simply Wall St's discounted cash flow (DCF) analysis estimates an intrinsic value of $2.11 per share, while the current price is over ten times that figure, indicating a potential overvaluation of 1179.1%. The stock has experienced volatility, including a recent 6.4% drop in the past week, reflecting mixed investor sentiment around its satellite-based Earth imaging business. Simply Wall St assigns a value score of 0 out of 6, highlighting red flags for prospective investors. These valuation concerns underline the importance of thorough analysis even amid impressive stock rallies.
Go toTop